Investigations on anti-Aspergillus properties of bacterial products

Letters in Applied Microbiology

Volumn 41, Issue 4, 2005, Pages 309-314

  Yadav, V ^a   Gupta, J ^a   Mandhan, R ^c   Chhillar, A K ^a   Dabur, R ^b   Singh, D D ^b   Sharma, G L ^a,b  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b BUNDELKHAND UNIVERSITY   (India)

^c KURUKSHETRA UNIVERSITY   (India)

Author keywords

Anti Aspergillus; Antifungal protein; Aspergillus; Bacterial products

Indexed keywords

ASSAYS; BACILLUS CEREUS; BACTERIOLOGY; BIOACTIVITY; ESCHERICHIA COLI; PROTEINS; SALMONELLA;

ANTI-ASPERGILLUS; ANTIFUNGAL ACTIVITIES; ANTIFUNGAL PROTEIN; BACTERIAL PRODUCT; BACTERIAL STRAINS; E. COLI; ESCHERICHIA COLI BL21; LYSATES; MICROBROTH; PROPERTY;

ASPERGILLUS;

BACTERIUM LYSATE;

BACTERIUM;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; BACILLUS CEREUS; BACTERIAL STRAIN; CONTROLLED STUDY; DILUTION; DRUG ACTIVITY; ESCHERICHIA COLI; FUNGUS IDENTIFICATION; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI; SPORE GERMINATION; STREPTOCOCCUS PNEUMONIAE; STREPTOMYCES;

ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; BACILLUS CEREUS; BACTERIA (MICROORGANISMS); ENTEROBACTER AEROGENES; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOMYCES THERMOVULGARIS;

EID: 25844502078     PISSN: 02668254     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-765X.2005.01772.x     Document Type: Article

References (19)

1. Bormann, C., Baier, D., Horr, I., Raps, C., Berger, J., Jung, G. and Schwarz, H. (1999) Characterization of a novel, antifungal, chitin-binding protein from Streptomyces tendae Tu901 that interferes with growth polarity. J Bacteriol 181, 7421-7429.
2. Furtado, N.A.J.C., Said, S., Ito, I.Y. and Bastos, J.K. (2002) The antimicrobial activity of Aspergillus fumigatus is enhanced by a pool of bacteria. Microbiol Res 157, 207-211.
3. Georg, K.J. and Schlorer, E. (1998) Probiotic therapy of pseudomembranous colitis. Combination of intestinal lavage and oral administration of Escherichia coli. Dtsch Med Wochenschr 123, 1274-1278.
4. Georgopapadakou, N. and Walsh, T. (1996) Antifungal agents: chemotherapeutic targets and immunologic stratagies. Antimicrob Agents Chemother 40, 279-291.
5. Kim, K.K., Kang, J.G., Moon, S.S. and Kang, K.Y. (1999) Isolation and identification of antifungal N-Butylbenzenesulphonamide produced by Pseudomonas sp AB2. J Antibiot 53, 131-136.
6. Laemmli, U.K. and Favre, M. (1973) Maturation of the head of bacteriophage T 4. DNA packaging events. J Mol Biol 50, 575-599.
7. Landy, M., Warren, G., Roseman, S. and Colio, L. (1948) Bacillomycin, an antibiotic from Bacillus subtilis, active against pathogenic fungi. Proc Soc Exp Biol Med 67, 539-541.
8. Latoud, C., Peypoux, F., Michel, G., Genet, R. and Morgat, J. (1986) Interactions of antibiotics of the iturin group with human erythrocytes. Biochim Biuphys Acta 35, 526-535.
9. Lee, C.H., Kim, S.H., Hyun, B.C., Suh, J.W., Yon, C., Kim, C.O., Lim, Y.A. and Kim, C.S. (1994) Cepacidine A, a novel antifungal antibiotic produced by Pseudomanas cepacia. I. Taxonomy, production, isolation, and biological activity. J Antibiot 47, 1402-1405.
10. Lehrer, R.I., Lichtenstein, A.K. and Ganz, T. (1993) Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 11, 105-128.
11. Magnusson, J. and Schnürer, J. (2001) Lactobacillus coryniformis subsp. coryniformis Strain Si3 produces a broad-spectrum proteinaceous antifungal compound. Appl Environ Microbiol 67, 1-5.
12. Matricardi, P.M., Bjorksten, B., Bonini, S., Bousquet, J., Djukenovic, R., Dreborg, S., Gereda, J., Mailing, H.J. et al. (2003) Microbial products in allergy prevention and therapy. Allergy 58, 461-471.
13. Molina, A., Segura, A. and Garcia, O.F. (1993) Lipid transfer proteins from barley and maize leaves are potent inhibitors of bacterial and fungal plant pathogens. FEBS Lett 316, 119-122.
14. Rajesh and Sharma, G.L. (2002) Studies on antimycotic properties of Datura metel. J Ethnopharmacol 80, 193-197.
15. Richardson, M.D. and Kokki, M.H. (1998) Antifungal therapy in bone marrow failure. Br J Haematol 100, 619-628.
16. Selitrennikoff, C.P. (2001) Antifungal proteins. Appl Environ Microbiol 67, 2883-2894.
17. Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., Fujimoto, E.K., Goeke, N.M. et al. (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150, 76-85.
18. Sorensen, K., Kim, K.-H. and Takemoto, J.Y. (1996) In vitro antifungal and fungicidal activities and erythrocytes toxicities of Pseudomonas syringae pv. Syringae. Antimicrob Agents Chemother 40, 2710-2713.
19. Woo, J.H., Kitamura, E., Myuoga, H. and Yuto, K. (2002) An antifungal protein from the marine bacterium Streptomyces species strain AP 77 is specific for Pythium Porphyrae, a causative agent of red rot disease in Porphyra spp. Appl Environ Microbiol 68, 2666-2675.